166 related articles for article (PubMed ID: 8301680)
1. Ocular manifestations in bone marrow transplantation.
Spires R
J Ophthalmic Nurs Technol; 1993; 12(5):208-10. PubMed ID: 8301680
[TBL] [Abstract][Full Text] [Related]
2. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients.
Calissendorff B; el Azazi M; Lönnqvist B
Bone Marrow Transplant; 1989 Nov; 4(6):675-8. PubMed ID: 2819286
[TBL] [Abstract][Full Text] [Related]
3. Ocular complications in high-dose chemoradiotherapy and marrow transplantation.
Jack MK; Hicks JD
Ann Ophthalmol; 1981 Jun; 13(6):709-11. PubMed ID: 7020552
[TBL] [Abstract][Full Text] [Related]
4. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
5. Ocular findings after bone marrow transplantation in a pediatric population.
Suh DW; Ruttum MS; Stuckenschneider BJ; Mieler WF; Kivlin JD
Ophthalmology; 1999 Aug; 106(8):1564-70. PubMed ID: 10442905
[TBL] [Abstract][Full Text] [Related]
6. Ocular complications of bone marrow transplantation.
Livesey SJ; Holmes JA; Whittaker JA
Eye (Lond); 1989; 3 ( Pt 3)():271-6. PubMed ID: 2693135
[TBL] [Abstract][Full Text] [Related]
7. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
8. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
9. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
[TBL] [Abstract][Full Text] [Related]
10. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
12. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
Mori A; Hashino S; Imamura M; Kahata K; Kawakami H; Shibata M; Kobayashi S; Tanaka J; Asaka M
Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
[TBL] [Abstract][Full Text] [Related]
14. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
15. Sjögren-like syndrome after bone marrow transplantation.
Kosrirukvongs P; Chirapapaisan N; Visuthisakchai S; Issaragrisil S; Gonggetyai V
J Med Assoc Thai; 2008 Nov; 91(11):1739-47. PubMed ID: 19127798
[TBL] [Abstract][Full Text] [Related]
16. [Ocular complications of long-term survival of bone marrow transplantation. A prospective study with 21 patients].
Bautista Juanes JA; Theischen M; Beelen DW; Pauleikhoff D; Koch JM; Waubke TN; Wessing A
Klin Monbl Augenheilkd; 1993 Feb; 202(2):110-5. PubMed ID: 8487463
[TBL] [Abstract][Full Text] [Related]
17. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
18. Progressive corneal vascularization caused by graft-versus-host disease.
Mohammadpour M
Cornea; 2007 Feb; 26(2):225-6. PubMed ID: 17251819
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
[TBL] [Abstract][Full Text] [Related]
20. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Kujawa A; Rózycki R
Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]